Novel trends in celiac disease

29Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients. © 2011 CSI and USTC. All rights reserved.

Cite

CITATION STYLE

APA

Matthias, T., Neidhöfer, S., Pfeiffer, S., Prager, K., Reuter, S., & Gershwin, M. E. (2011, March). Novel trends in celiac disease. Cellular and Molecular Immunology. https://doi.org/10.1038/cmi.2010.68

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free